Orthofix Medical Inc. $OFIX Shares Purchased by AlphaQuest LLC

Key Points

• AlphaQuest LLC significantly increased its stake in Orthofix Medical by 258.1% in the 1st quarter, owning a total of 25,202 shares valued at approximately $411,000.
• Institutional investors and hedge funds currently hold 89.76% of Orthofix Medical’s stock, with several funds such as Lazard Asset Management and US Bancorp DE also increasing their positions.
• Orthofix Medical reported a quarterly loss of ($0.36) earnings per share, missing estimates by ($0.40), while generating revenue of $203.12 million for the quarter.

AlphaQuest LLC increased its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 258.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,202 shares of the medical device company's stock after acquiring an additional 18,165 shares during the period. AlphaQuest LLC owned about 0.06% of Orthofix Medical worth $411,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Lazard Asset Management LLC acquired a new position in Orthofix Medical during the 4th quarter worth about $45,000. US Bancorp DE lifted its stake in Orthofix Medical by 684.6% during the 1st quarter. US Bancorp DE now owns 5,673 shares of the medical device company's stock worth $93,000 after acquiring an additional 4,950 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in Orthofix Medical by 120.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company's stock worth $148,000 after acquiring an additional 4,627 shares in the last quarter. State of Wyoming lifted its stake in Orthofix Medical by 206.8% during the 4th quarter. State of Wyoming now owns 9,432 shares of the medical device company's stock worth $165,000 after acquiring an additional 6,358 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in Orthofix Medical during the 1st quarter worth about $164,000. Institutional investors and hedge funds own 89.76% of the company's stock.

Insider Activity at Orthofix Medical

In other news, insider Aviva Mcpherron sold 3,728 shares of the stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $10.51, for a total value of $39,181.28. Following the transaction, the insider owned 46,322 shares in the company, valued at approximately $486,844.22. This represents a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

OFIX has been the topic of several research reports. Wall Street Zen raised Orthofix Medical from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a research report on Friday, June 6th. Finally, Barrington Research raised Orthofix Medical to a "strong-buy" rating and set a $16.00 price target on the stock in a research report on Monday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $21.50.

Orthofix Medical Price Performance

OFIX stock opened at $14.51 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.50. The firm has a market capitalization of $573.00 million, a P/E ratio of -4.58 and a beta of 0.82. The business's 50-day moving average is $11.89 and its two-hundred day moving average is $13.54. Orthofix Medical Inc. has a 1 year low of $10.24 and a 1 year high of $20.73.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The medical device company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.40). Orthofix Medical had a negative net margin of 15.29% and a negative return on equity of 25.43%. The company had revenue of $203.12 million during the quarter, compared to analyst estimates of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. Analysts anticipate that Orthofix Medical Inc. will post -2.81 earnings per share for the current fiscal year.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix Medical Inc. (NASDAQ:OFIX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.